Research programme: glutamate receptor antagonists - Astellas Pharma
Alternative Names: AS1529122-FM; AS1655619-FM; YM 230888; YM 298198Latest Information Update: 16 Jul 2016
At a glance
- Originator Astellas Pharma
- Class Benzimidazoles
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pain in Japan (PO)
- 02 Oct 2006 Data presented at the 232nd American Chemical Society National Meeting (232nd-ACS-2006) have been added to the Pain pharmacodynamics section
- 25 May 2006 Preclinical trials in Pain in Japan (PO)